












































































impairment may not be related
to the virus
Sir,
We read the letter by Bendayan and Boitrelle, regarding our recent
paper reporting the impact of COVID-19 on male fertility, with
interest (Bendayan and Boitrelle, 2021).
As correctly stated in the letter, we found a high proportion of men
showing oligo-crypto-azoo-spermia about 1 month after recovery from
the disease (Gacci et al., 2021). In our paper, we evidenced the need
for a careful evaluation of the fertility status of men recovering from
COVID-19.
The official website of government of Hubei Province posted a
bulletin suggesting that men infected with severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) should undergo fertility checks
(Meng et al., 2021). On the other hand, SARS-Cov-2 infection can
damage several organs besides lungs, including the testis. Moreover,
COVID-19 predominantly affects male patients: therefore, the possible
impact on male fertility should not be ignored (Ding et al., 2004).
In particular, several evidences demonstrated that SARS-CoV-2 uses
the angiotensin-converting-enzyme 2 (ACE2) receptor to enter cells
and this could cause pathological injuries in multiple organs, including
testes which show a high expression of ACE2 receptor(Wang and Xu,
2020). Therefore, it seems mandatory to assess whether the virus can
infect the human reproductive tract and affect male fertility (Fu et al.,
2020; Stanley et al., 2020).
In our manuscript, we demonstrated that semen impairment (oligo/
crypto/azoospermia) and signs of genital tract inflammation (elevated
semen levels of IL-8 and leukocytospermia, both signs of male genital
tract inflammation) were related to Covid-19 severity (Gacci et al.,
2021).
Overall, our data are in agreement with those reported in a recent
systematic review based on 70 studies (23 quantitative 47 qualitative)
(Tur-Kaspa et al., 2021). The Authors tested the male and female re-
productive tracts of 404 adult COVID-19 patients with the aim to de-
termine if COVID-19 is an STD or not, and to evaluate its possible
effect on fertility. They concluded that COVID-19 may cause inflam-
mation of the testes, in 5–10% of male patients of reproductive age
and that this orchitis is highly correlated to the severity of the disease.
They also conclude that there is no evidence to support that COVID-
19 can be considered as a STD.
Several viral infections including HPV, HSV, HBV, HCV challenges
reproductive health and must be considered as a risk factor for male
infertility. All these viruses have been detected in semen and can im-
pair testicular function (Batiha et al., 2020). Some viruses such as MuV,
HIV and SARS-CoV can affect testicular cells, resulting in severe orchi-
tis, which can result in male infertility (Xu et al., 2006).
Bendayan and Boitrelle, in their letter, suggest that even fever
alone—a symptom observed in over 80% of patients infected by
COVID-19—could have a negative impact on the physiological scrotal
heat regulation, with the consequent semen impairment (Boitrelle and
Bendayan, 2021). Actually, COVID-19 patients, such as those affected
by influenza, suffer from fever, which may affect sperm production. It
is well demonstrated that febrile status can have a negative impact on
semen quality (Batiha et al., 2020), including an induction of DNA
damage (Xu et al., 2006). However, it should be noted that both
sperm count and motility were temporarily reduced more than one
month after fever episode, before going back to normal several weeks
after fever (Sergerie et al., 2007).
In addition to fever, COVID-19 patients underwent severe cycles of
medications, were hospitalized and may have a prolonged abstinence
period, as correctly indicated in the letter by Bendayan and Boitrelle
(2021). All these conditions may be involved in producing testicular
damage. However, at present, whether testicular damage is produced
by virus infection in the testes or is due to the associated pathological
condition, medications, etc. remains to be defined. Similarly, it is not
known, at present, whether testicular damage may persist for long
time.
In such a situation, we fully agree with Bendayan and Boitrelle
(2021) regarding the need for a re-evaluation of men that have been
affected by COVID-19 at least 3 months following complete healing,
which is presently under investigation in our laboratory.
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